Literature DB >> 12231319

Role of intraocular pressure measurement on the day of phacoemulsification cataract surgery.

Andrew C Browning1, Amar Alwitry, Robin Hamilton, Alan Rotchford, Archana Bhan, Winfried M Amoaku.   

Abstract

PURPOSE: To determine whether measurement of intraocular pressure (IOP) preoperatively or in the early postoperative period is an accurate predictor of raised IOP 24 hours after cataract surgery.
SETTING: Department of Ophthalmology, Queen's Medical Centre, Nottingham, United Kingdom.
METHODS: This prospective study comprised 101 eyes of 101 patients having phacoemulsification cataract surgery. The IOP was measured by Goldmann applanation tonometry preoperatively and 2 to 3 hours, 6 to 8 hours, and 22 to 24 hours postoperatively. The relationship between the same-day and next-day IOP readings was examined.
RESULTS: One hundred patients completed the study. The IOP at 22 to 24 hours was significantly correlated with the IOP preoperatively (correlation coefficient [r] 0.54; 95% confidence interval [CI], 0.38-0.67) and at 6 to 8 hours (r = 0.56; 95% CI, 0.41-0.68). In contrast, the IOP measurement at 2 to 3 hours correlated relatively poorly with the next-day IOP (r = 0.33; 95% CI, 0.14-0.49). Twelve patients had an IOP of 26 mm Hg or higher at 22 to 24 hours. The risk of this outcome increased significantly with higher IOP values preoperatively and, to a lesser extent, with a raised IOP at 6 to 8 hours. Glaucoma and ocular hypertension were associated with a 2.9-fold increased risk (95% CI, 0.67-12.8) of a next-day IOP of 26 mm Hg or higher.
CONCLUSIONS: Preoperative IOP or a diagnosis of glaucoma or ocular hypertension were significant risk factors for raised next-day IOP after small-incision phacoemulsification. It may be possible to select patients at greater risk of prolonged ocular hypertension before surgery for prophylactic IOP-lowering treatment. This would minimize patient morbidity and reduce the number of patients requiring next-day review, resulting in significant health economic savings.

Entities:  

Mesh:

Year:  2002        PMID: 12231319     DOI: 10.1016/s0886-3350(02)01279-8

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  First postoperative day intraocular pressure rise in resident-performed cataract surgery.

Authors:  R Chaudhary; A Kadyan
Journal:  Eye (Lond)       Date:  2012-04-27       Impact factor: 3.775

2.  Increased intraocular pressure on the first postoperative day following resident-performed cataract surgery.

Authors:  J Y Kim; M-W Jo; S C Brauner; Z Ferrufino-Ponce; R Ali; S L Cremers; B An Henderson
Journal:  Eye (Lond)       Date:  2011-04-29       Impact factor: 3.775

3.  Is the 1-day postoperative IOP check needed post uncomplicated phacoemulsification in patients with glaucoma and ocular hypertension?

Authors:  A Gupta; S A Vernon
Journal:  Eye (Lond)       Date:  2015-02-20       Impact factor: 3.775

4.  Is visual outcome compromised when next day review is omitted after phacoemulsification surgery? A randomised control trial.

Authors:  C G Tinley; A Frost; K N Hakin; W McDermott; P Ewings
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

5.  Comparison of brimonidine-timolol and dorzolamide-timolol in the management of intraocular pressure increase after phacoemulsification.

Authors:  Adem Turk; Osman Melih Ceylan; Gokcen Gokce; Mehmet Borazan; Mehmet Kola
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

6.  First postoperative day review after uneventful phacoemulsification cataract surgery: is it necessary?

Authors:  Irini P Chatziralli; Theodoros N Sergentanis; Evgenia Kanonidou; Leonidas Papazisis
Journal:  BMC Res Notes       Date:  2012-06-27

7.  Impact of dexamethasone intraocular suspension 9% on intraocular pressure after routine cataract surgery: post hoc analysis.

Authors:  Cynthia Matossian; John Hovanesian; Jason Bacharach; Dario Paggiarino; Keyur Patel
Journal:  J Cataract Refract Surg       Date:  2021-01-01       Impact factor: 3.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.